Work

P3.04-27 An Allogeneic Tumor Cell Lysate Vaccine Induces Immune Responses to Lung Cancer Associated Antigens: Preliminary Results of a Phase II Study

Year: 2018

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.08.1734

Authors: M. Zhang, J. Hong, T. Kunst, C. Bond, J. Yeray, M. Lee, A. Yuno, S.L. Lee, L. Xia, C. Kenney, C. Warga, T. Guerrero, T. Ripley, C. Hoang, S. Gnjatic, J. Gildersleeve, J. Trepel, D. Schrump

Institutions: National Institutes of Health, National Cancer Institute, Tisch Cancer Institute, Center for Cancer Research

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2898269095

FWCI:

Cites:

Cited by:

Related to: 10